Funding options for the management of major depressive disorder in Canada

Major depressive disorder (MDD) is highly prevalent in Canada and the care and support of individuals affected by this illness is associated with high societal costs. In this article, we provide a sample case of a patient diagnosed with MDD, and present different management and funding options that would be available to her in the current health care system. We demonstrate that there exists a large degree of variability in services that can be accessed based on type of insurance coverage. As a result of the high cost of care for MDD, many patients have immense difficulty funding a prescription for antidepressants or a course of psychological therapy. Yet leaving mental illness untreated is associated with greater costs due to worse patient outcomes. Increased investment in effective prevention and early intervention efforts may be one way to bring about long-term cost savings.